Clinical Trial Update: Predictive Value of Drug Elimination Gene Polymorphisms on Clearance and Dose Adjustment of Sunitinib in Cancer Patients

View source ↗

Summary

This clinical trial evaluated whether genetic polymorphisms involved in drug elimination can predict sunitinib clearance in cancer patients and inform dose adju…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Cancer | Status: COMPLETED